FDAnews
www.fdanews.com/articles/84712-cost-containment-strategies-restrict-innovation-frost-sullivan

COST-CONTAINMENT STRATEGIES RESTRICT INNOVATION -- FROST & SULLIVAN

February 20, 2006

Cost containment and the rationalisation of medical resources are the two major prevailing trends in the European medical devices industry today. This is largely due to increasing cost pressures facing the industry as a result of diminishing healthcare budgets.
PRnewswire